Longevity.Technology (@LongevityTech)· LongevityTech·· 2 小时前评分8
勃林格殷格翰扩大肾病合作至心血管靶点
Boehringer Ingelheim widens its kidney-disease partnership to cardiovascular targets, in a deal that could exceed $250 million.
导读
勃林格殷格翰将其肾病合作扩展至心血管靶点，交易金额可能超过2.5亿美元。 https://vist.ly/5nbxs #longevity #boehringeringelheim #kidneydisease #cardiovascular #partnership
来源：Longevity.Technology (@LongevityTech) · x.com